Cargando…
Phage Engineering for Targeted Multidrug-Resistant Escherichia coli
The lytic bacteriophages have potential application value in the treatment of bacterial infections. However, the narrow host spectrum of these phages limits their range of clinical application. Here, we demonstrate the use of scarless Cas9-assisted recombination (no-SCAR) gene-editing technology to...
Autores principales: | Song, Jiaoyang, Liu, Zhengjie, Zhang, Qing, Liu, Yuqing, Chen, Yibao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004113/ https://www.ncbi.nlm.nih.gov/pubmed/36768781 http://dx.doi.org/10.3390/ijms24032459 |
Ejemplares similares
-
Disarm The Bacteria: What Temperate Phages Can Do
por: Zhou, Shiyue, et al.
Publicado: (2023) -
Phage-Derived Depolymerase: Its Possible Role for Secondary Bacterial Infections in COVID-19 Patients
por: Nazir, Amina, et al.
Publicado: (2023) -
Lysogenic Conversion and Phage Resistance Development in Phage Exposed Escherichia coli Biofilms
por: Moons, Pieter, et al.
Publicado: (2013) -
Diversity of P1 phage-like elements in multidrug resistant Escherichia coli
por: Venturini, Carola, et al.
Publicado: (2019) -
Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli
por: Vera-Mansilla, Javiera, et al.
Publicado: (2022)